These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1468430)

  • 1. Comparative in vitro activity of clarithromycin. Spanish Collaborative Group.
    Loza E; Martínez Beltrán J; Baquero F; León A; Cantón R; Garijo B
    Eur J Clin Microbiol Infect Dis; 1992 Sep; 11(9):856-66. PubMed ID: 1468430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.
    Benson C; Segreti J; Kessler H; Hines D; Goodman L; Kaplan R; Trenholme G
    Eur J Clin Microbiol; 1987 Apr; 6(2):173-8. PubMed ID: 2954818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of rokitamycin compared with that of other macrolides.
    Yu KW; Briones F; Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
    Neu HC; Chin NX; Gu JW
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():83-94. PubMed ID: 1328138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.
    Rolston KV; Ho DH; LeBlanc B; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):30-3. PubMed ID: 2137413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiologic activity of the newer macrolide antibiotics.
    McCracken GH
    Pediatr Infect Dis J; 1997 Apr; 16(4):432-7. PubMed ID: 9109155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.
    Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV; Shayegani M
    J Antimicrob Chemother; 1988 May; 21(5):565-70. PubMed ID: 2968968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.
    Benson CA; Segreti J; Beaudette FE; Hines DW; Goodman LJ; Kaplan RL; Trenholme GM
    Antimicrob Agents Chemother; 1987 Feb; 31(2):328-30. PubMed ID: 2952063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Azithromycin: critical points].
    Philippon A; Cluzel R; Soussy CJ
    Pathol Biol (Paris); 1995 Jun; 43(6):488-97. PubMed ID: 8539070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarithromycin and azithromycin: new macrolide antibiotics.
    Piscitelli SC; Danziger LH; Rodvold KA
    Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
    Peters DH; Clissold SP
    Drugs; 1992 Jul; 44(1):117-64. PubMed ID: 1379907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of clarithromycin, cefprozil, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens.
    Ritchie DJ; Hopefl AW; Milligan TW; Byrne JE; Maddux MS
    Clin Ther; 1993; 15(1):107-13. PubMed ID: 8458040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
    Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates.
    Felmingham D; Robbins MJ; Ingley K; Mathias I; Bhogal H; Leakey A; Ridgway GL; Grüneberg RN
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():43-9. PubMed ID: 9222069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].
    Soussy CJ; Le Van Thoi J; Cluzel M; Derlot E; Kitzis MD
    Pathol Biol (Paris); 1990 May; 38(5):401-6. PubMed ID: 2142274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the in-vitro activity of clarithromycin, a new macrolide antibiotic, with erythromycin and other oral agents.
    King A; Phillips I
    J Hosp Infect; 1991 Sep; 19 Suppl A():3-9. PubMed ID: 1684981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of MC-352, a new 16-membered macrolide.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1699-702. PubMed ID: 1416853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
    Eliopoulos GM; Reiszner E; Ferraro MJ; Moellering RC
    J Antimicrob Chemother; 1987 Nov; 20(5):671-5. PubMed ID: 2962974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.